-
Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme).
Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):177-85
PMID: 9212908
-
Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3318-22
PMID: 7724560
-
In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.
Nucleic Acids Res. 1997 Aug 15;25(16):3290-6
PMID: 9241243
-
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
Lab Invest. 1997 Oct;77(4):379-88
PMID: 9354772
-
Biosynthesis in vitro of fucose-containing glycosphingolipids in human neuroblastoma IMR-32 cells.
Proc Natl Acad Sci U S A. 1978 Jan;75(1):289-93
PMID: 272643
-
Characterization of oligonucleotide transport into living cells.
Proc Natl Acad Sci U S A. 1989 May;86(10):3474-8
PMID: 2726730
-
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6454-8
PMID: 2549537
-
Intracellular distribution of microinjected antisense oligonucleotides.
Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2702-6
PMID: 1849273
-
Rapid nuclear accumulation of injected oligodeoxyribonucleotides.
New Biol. 1990 Dec;2(12):1091-100
PMID: 1708281
-
Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.
Bioconjug Chem. 1990 Mar-Apr;1(2):149-53
PMID: 1965625
-
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7595-9
PMID: 1881900
-
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
J Biol Chem. 1991 Sep 25;266(27):18162-71
PMID: 1680858
-
Binding of oligonucleotides to cell membranes at acidic pH.
Biochem Biophys Res Commun. 1991 Dec 31;181(3):1343-51
PMID: 1764085
-
The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.
Anticancer Drug Des. 1992 Apr;7(2):115-29
PMID: 1575885
-
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Mol Pharmacol. 1992 Jun;41(6):1023-33
PMID: 1352033
-
Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides.
J Biol Chem. 1992 Jun 25;267(18):12436-9
PMID: 1618751
-
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
PMID: 7638184
-
Cellular and molecular barriers to gene transfer by a cationic lipid.
J Biol Chem. 1995 Aug 11;270(32):18997-9007
PMID: 7642560
-
The therapeutic potential of antisense oligonucleotides.
Bioessays. 1995 Dec;17(12):1055-63
PMID: 8634067
-
Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates.
Pharm Res. 1995 Oct;12(10):1548-53
PMID: 8584498
-
Novel polyaminolipids enhance the cellular uptake of oligonucleotides.
J Biol Chem. 1995 Dec 29;270(52):31391-6
PMID: 8537413
-
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3176-81
PMID: 8622909
-
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.
Nucleic Acids Res. 1996 Jun 1;24(11):2176-82
PMID: 8668551
-
Progress in antisense oligonucleotide therapeutics.
Annu Rev Pharmacol Toxicol. 1996;36:107-29
PMID: 8725384
-
Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.
Pharm Res. 1996 Mar;13(3):404-10
PMID: 8692733
-
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Mol Pharmacol. 1996 Aug;50(2):236-42
PMID: 8700129
-
Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Cancer Res. 1996 Aug 1;56(15):3499-507
PMID: 8758918
-
Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.
J Pharmacol Exp Ther. 1996 Sep;278(3):1362-72
PMID: 8819524
-
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Mol Pharmacol. 1996 Oct;50(4):808-19
PMID: 8863825
-
Mechanism of oligonucleotide release from cationic liposomes.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11493-8
PMID: 8876163
-
Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
Pharm Res. 1996 Sep;13(9):1367-72
PMID: 8893276
-
Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.
Mol Pharmacol. 1996 Dec;50(6):1487-94
PMID: 8967969
-
Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.
Leuk Res. 1996 Nov-Dec;20(11-12):925-30
PMID: 9009250
-
Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides.
Antisense Nucleic Acid Drug Dev. 1996 Winter;6(4):291-9
PMID: 9012865
-
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.
Biochemistry. 1997 Mar 11;36(10):3008-17
PMID: 9062132
-
Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery.
J Pharm Sci. 1997 Jun;86(6):762-4
PMID: 9188063
-
Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7031-5
PMID: 1495997
-
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
Nature. 1992 Sep 3;359(6390):67-70
PMID: 1522889
-
Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
Exp Cell Res. 1992 Oct;202(2):391-7
PMID: 1397092
-
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
J Biol Chem. 1992 Oct 5;267(28):19954-62
PMID: 1400312
-
Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker.
Antisense Res Dev. 1992 Spring;2(1):17-25
PMID: 1422083
-
Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes.
Pharm Res. 1992 Oct;9(10):1235-42
PMID: 1448419
-
Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.
Nucleic Acids Res. 1992 Nov 11;20(21):5691-8
PMID: 1454532
-
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1048-52
PMID: 8430072
-
Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.
Biochem Biophys Res Commun. 1993 Feb 15;190(3):952-60
PMID: 8094959
-
Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Antisense Res Dev. 1993 Spring;3(1):53-66
PMID: 8495106
-
Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
Nucleic Acids Res. 1993 Jul 25;21(15):3567-73
PMID: 8346033
-
Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
J Pharmacol Exp Ther. 1993 Dec;267(3):1181-90
PMID: 8166890
-
The kinetic aspects of intracellular fluorescence labeling with TMA-DPH support the maturation model for endocytosis in L929 cells.
J Cell Biol. 1994 May;125(4):783-94
PMID: 8188746
-
Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
J Biol Chem. 1994 Jun 10;269(23):16416-24
PMID: 7911467
-
Gene inhibition using antisense oligodeoxynucleotides.
Nature. 1994 Nov 24;372(6504):333-5
PMID: 7969490
-
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11762-6
PMID: 7972137
-
Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
Nucleic Acids Res. 1994 Nov 11;22(22):4681-8
PMID: 7984418
-
Functions and structures of ribonuclease H enzymes.
Subcell Biochem. 1995;24:377-422
PMID: 7900182
-
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
J Clin Invest. 1995 Apr;95(4):1814-23
PMID: 7706488
-
Developing oligonucleotide therapeutics for human leukemia.
Anticancer Drug Des. 1997 Jul;12(5):341-58
PMID: 9236851